Tryp Therapeutics, Inc. (CSE: TRYP OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases...
Source: Streetwise Reports 09/12/2022 One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving...
The article Algernon Pharmaceuticals Receives Approval for Phase 1 DMT Study was originally published on Microdose. For more on Algernon and their DMT...
The article Microdose Brings Psychedelics to the Concordia Summit was originally published on Microdose. While Davos and the World Economic Forum get...
The article MindMed Faces Tough IP Questions (and Publishes Positive Trial Results) was originally published on Microdose. MindMed’s been in the news...
Source: chuyuss / Shutterstock.com Some solar stocks are on the move Thursday thanks to a few different catalysts worth looking into. First off we have...
Source: shutterstock.com/T. Schneider ShiftPixy (NASDAQ:PIXY) stock is rocketing higher on Thursday after the company announced plans to spin off ShiftPixy...
Any analyst knows that market-reactive swings aren’t really a true indicator of what is going on inside a company. The post Psychedelics Stock Swings...
The article News You Might Have Missed: Sep 6th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
CURE Pharmaceutical Holding Corp. (OTC: CURR), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June...